Skip to main content
. 2024 Apr 11;34(6):e13261. doi: 10.1111/bpa.13261

FIGURE 3.

FIGURE 3

Immunofluorescence stained with anti‐pTDP‐43 in patients with C9ORF72‐ALS, sporadic‐ALS, and non‐ALS patient. (A–C) A remarkable amount of pTDP‐43 aggregates in myofibers from a ALS patient with C9ORF72 (ID: ALS‐06). (D–F) Obvious pTDP‐43 accumulation in a sporadic‐ALS patient (ID: ALS‐11). (G–I) No pTDP‐43 deposit in non‐ALS patient, a lipid storage myopathy (LSM) with ETFDH gene mutation (ID: Ctrl‐25). Scale bar, 75 μm.